S04 From Orphan GPCRs to Drug Targets

Program: Symposia
Basic Session
Friday, April 1, 2016: 9:45 AM-11:15 AM
Room 160 (BCEC)
Jean-Pierre Vilardaga, PhD, University of Pittsburgh, Pittsburgh, PA

Nothing to Disclose: JPV
9:45 AM
Olivier Civelli, PhD, Pharmacology, University of California, Irvine, Irvine, CA
Nothing to Disclose: OC
10:15 AM
Melanie Houston Cobb, PhD, University of Texas Southwestern, Dallas, TX
Nothing to Disclose: MHC
10:45 AM
Robert G. Bennett, PhD, Department of Medical Research, VA Nebraska-Western Iowa Health Care System, Omaha, NE
Nothing to Disclose: RGB
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire